HALB OTC
Halberd Corporation
1W: +100.0%
1M: +122.2%
3M: +100.0%
YTD: +33.3%
1Y: -13.0%
3Y: -77.8%
5Y: -93.7%
$0.00
+0.00 (+81.82%)
Weekly Expected Move ±54.3%
$-0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$1.0M
52W Range0.0006-0.0027
Volume175,116
Avg Volume797,913
Beta0.13
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOWilliam A. Hartman
Employees3
SectorHealthcare
IndustryBiotechnology
IPO Date2012-09-25
Websitehalberdcorporation.com
PO Box 25
Jackson Center, PA 16133
US
Jackson Center, PA 16133
US
814 786 8849
About Halberd Corporation
Halberd Corporation is a biotechnology firm dedicated to pioneering therapies for neurodegenerative conditions. The company's therapeutic focus encompasses a broad range of serious illnesses, including post-traumatic stress disorder (PTSD) and chronic traumatic encephalopathy (CTE), Alzheimer's disease, Parkinson's disease, various forms of cancer, and disorders impacting the blood and cerebrospinal fluid. Established in 2009, Halberd Corporation operates from its headquarters in Jackson Center, Pennsylvania.
Recent Insider Trades
No insider trades found